Prezzo di chiusura
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
76,6 TWD | +0,13% | +0,79% | -4,73% |
Attività
Vendite per attività
TWD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Cancer Drugs
44,1
%
| 2 970 | 58,7 % | 2 430 | 44,1 % | -18,17% |
Anti-infective Drugs
18,4
%
| - | - | 1 013 | 18,4 % | - |
Invest
14,8
%
| - | - | 814 | 14,8 % | - |
Export Sales and OEM
14,5
%
| - | - | 797 | 14,5 % | - |
Medical Insurance
7,0
%
| 179 | 3,5 % | 386 | 7,0 % | +115,77% |
Other
1,2
%
| 283 | 5,6 % | 65 | 1,2 % | -76,87% |
Vendite per regione
TWD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Taiwan
87,9
%
| 4 596 | 90,8 % | 4 841 | 87,9 % | +5,33% |
Other Countries
7,2
%
| 466 | 9,2 % | 399 | 7,2 % | -14,37% |
America
4,8
%
| - | - | 266 | 4,8 % | - |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Sara Hou
CEO | Chief Executive Officer | - | 18/04/22 |
Guo Jiang Zhang
DFI | Director of Finance/CFO | - | 31/12/15 |
Shu Fen Huang
CMP | Compliance Officer | - | 18/04/22 |
Nai Wei Liu
ADM | Chief Administrative Officer | - | 04/12/18 |
Shih-Chou Chen
IRC | Investor Relations Contact | - | - |
Jung Liang Kao
AUD | Comptroller/Controller/Auditor | - | 26/03/21 |
Wen Po Huang
PRN | Corporate Officer/Principal | - | 04/11/21 |
Jen-Yang Chang
HRO | Human Resources Officer | - | 01/05/19 |
Shu-Wen Wang
AUD | Comptroller/Controller/Auditor | - | 13/08/15 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Wen Hua Chang
BRD | Director/Board Member | - | 24/07/95 |
Hsiu Chi Chang
BRD | Director/Board Member | - | 24/06/16 |
Tzu Chiang Yang
BRD | Director/Board Member | 68 | 24/06/16 |
Tien Fu Lin
BRD | Director/Board Member | - | 24/06/16 |
Chuan Lin
CHM | Chairman | 72 | 22/11/18 |
Tui Tsai
BRD | Director/Board Member | - | 24/06/16 |
Ming-Ling Hsueh
BRD | Director/Board Member | 68 | 24/06/16 |
Ying Ying Liao
BRD | Director/Board Member | - | 24/06/16 |
Carl Hsiao
BRD | Director/Board Member | - | 26/03/19 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 248 650 000 | 200 715 959 ( 80,72 %) | 0 | 80,72 % |
Coordinate società
Settore
Vendite per attività
Vendite per regione
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-4,73% | 584 Mln | |
+25,83% | 661 Mrd | |
+27,00% | 566 Mrd | |
-6,76% | 352 Mrd | |
+20,34% | 332 Mrd | |
+3,00% | 283 Mrd | |
+13,09% | 231 Mrd | |
+5,46% | 200 Mrd | |
-9,61% | 195 Mrd | |
-6,26% | 145 Mrd |
- Borsa valori
- Azioni
- Azione 4105
- Società TTY Biopharm Company Limited